MENU

ZBIO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Zenas Biopharma (ZBIO) Ownership - Who owns Zenas Biopharma?

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

328.06M

P/E Ratio

N/A

Total Cash

386.8M

Projected Growth

N/A

Total Debt

384K

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

9.26

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

Fundamentals

ZBIO

Capitalization

328M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

387M

Total Cash/Share

9.26

Total Debt

384K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0%

Revenue

0

ROE

N/A

Book Value

359M

P/B Ratio

0.91

Cash Flow

N/A

Earnings

-3.09

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

4K

Current Ratio

8.95

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-132.91M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-52.94

Shares Held By Institutions

513M

Shares Outstanding - Current

41.8M

Total Liabilities

44M

Total Volume MTD

N/A

Value

1

Gain YTD

-4.151

View a ticker or compare two or three

VS

VS

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ZBIO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details